AnalystBro Research
Research
Company valuation reports, peer comparisons, results notes, industry reports and macro views, built from company filings and official data and independently reviewed before publishing. Company reports show their full model as view-only sheets. Facts and estimates, not investment advice.
3 articles.
Bangladesh All Bangladesh research →
Company · DSE:ACMEPL · Chemicals, paints & gases · Analysis · 01 Nov 2026
ACME Pesticides: revenue down 71% in four years, a gross loss, receivables at 441 days and a qualified audit
Revenue fell from BDT 1,683m (FY2021) to BDT 482m (FY2025) and another 22% in the nine months to March 2026; the company sells below cost, collects slowly, has not paid its lessor or bank, and its IPO cash sits frozen at Southeast Bank.
Company · DSE:ACIFORMULA · Chemicals, paints & gases · Analysis · 01 Nov 2026
ACI Formulations: crop care earns the profit, paint and aerosol lose money, and BDT 2.4bn is lent to the ACI group
FY2026 consolidated EPS rose 1.4% to BDT 7.96 on a 20% dividend, but operating cash flow was negative for the year; inter-company receivables reached BDT 2.38bn in September 2025 while bank debt rose to BDT 4.36bn.
Company · DSE:LINDEBD · Chemicals, paints & gases · Analysis · 29 Oct 2026
Linde Bangladesh: a debt-free gases business earning BDT 23 a share after the welding exit; energy costs cut Q3 2026 profit 19%
Revenue rose 12.1% in H1 2026 and the operating margin reached 21.8%, but EPS fell from BDT 80.55 (2021) to 22.60 (2025) once the welding business went to ESAB; the stock trades at 27.1x trailing earnings and 2.9x book.